Smith & Nephew Plc
15 April 2008
Timing of Smith & Nephew first quarter results
15 April 2008
Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business,
will be announcing its results for the first quarter ending 29 March 2008 on
Thursday 1 May 2008 at 11am BST/6.00am Eastern. This will be followed by a
conference call with financial analysts at 12 noon BST/7.00am Eastern, which can
be heard live via webcast on the Smith & Nephew website at www.smith-nephew.com
and available on the site archive shortly afterwards.
About Us
Smith & Nephew is a global medical technology business, specialising in
Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy
and Advanced Wound Management products. Smith & Nephew is a global leader in
arthroscopy and advanced wound management and is one of the leading global
orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company
prides itself on the strength of its relationships with its surgeons and
professional healthcare customers, with whom its name is synonymous with high
standards of performance, innovation and trust. The Company operates in 32
countries around the world. Annual sales in 2007 were $3.4 billion.
Enquiries:
Investors/Analysts
Julie Allen Tel: +44 (0)20 7401 7646
Corporate Affairs Co-ordinator
Smith & Nephew plc
Media
Jon Coles Tel: +44 (0) 20 7404 5959
Brunswick - London
Cindy Leggett-Flynn Tel: +1 (212) 333 3810
Brunswick - New York
This information is provided by RNS
The company news service from the London Stock Exchange XBBX
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.